Using a geneset metascore analysis, we identified immune-related pathways, in particular response to interferon-gamma and antigen processing and presentation, as the pathways that contribute most to our lung cancer risk scores (Fig. 4b) in both current and former smokers. This evidence concerns the gene IFNG and lung cancer.